Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Pediatr Nephrol. 2014 Dec 20;30(6):975–982. doi: 10.1007/s00467-014-3028-8

Fig. 1.

Fig. 1

Changes in plasma angiotensinogen (AGT) in pediatric patients with immunoglobulin A nephropathy (IgAN) after renin–angiotensin system (RAS) blockade (a). Changes in logarithmically transformed urinary AGT/urinary creatinine ratio (Log[UAGT/UCre]) in pediatric patients with IgAN after RAS blockade (b). Changes in logarithmically transformed urinary transforming growth factor beta (TGF-β)/creatinine ratio (Log[UTGF-β/UCre]) in pediatric patients with IgAN after RAS blockade (c). Each marker and line represents an individual participant in the study